7Baggers
 Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (T  The National Law Review Wed, 01 Jul 2026 08:31:26 GMT
 Discipline and Rules-Based Execution in TIL Response  Stock Traders Daily Tue, 30 Jun 2026 07:00:00 GMT
 enterprise value to ebit forward of instil bio, inc. – nasdaq:til  TradingView Tue, 30 Jun 2026 04:43:04 GMT
 Price to book forward of Instil Bio, Inc. – NASDAQ:TIL  TradingView Mon, 29 Jun 2026 12:54:00 GMT
 price to sales forward of instil bio, inc. – nasdaq:til  TradingView Mon, 29 Jun 2026 12:22:11 GMT
 instil bio inc (til) valuation: pe, pb & fair value analysis  TradingKey Tue, 23 Jun 2026 07:00:00 GMT
 instil bio inc (til) valuation: pe, pb & fair value analysis  TradingKey Fri, 19 Jun 2026 20:52:12 GMT
 behavioral patterns of til and institutional flows  Stock Traders Daily Fri, 19 Jun 2026 14:24:02 GMT
 instil bio inc (til) valuation: pe, pb & fair value analysis  TradingKey Thu, 18 Jun 2026 07:00:00 GMT
 Instil Bio Inc (TIL) Institutional Confidence  TradingKey Wed, 17 Jun 2026 20:54:47 GMT
 [8-K] Instil Bio, Inc. Reports Material Event  Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
 instil bio shareholders back directors and auditor at meeting  TipRanks Thu, 11 Jun 2026 07:00:00 GMT
 (TIL) Movement Within Algorithmic Entry Frameworks  Stock Traders Daily Mon, 08 Jun 2026 13:16:02 GMT
 how (til) movements inform risk allocation models  Stock Traders Daily Thu, 28 May 2026 11:46:02 GMT
 til news | instil bio inc (nasdaq:til)  ChartMill Thu, 28 May 2026 07:00:00 GMT
 trading systems reacting to (til) volatility  Stock Traders Daily Sun, 17 May 2026 10:38:02 GMT
 instil bio q1 net loss narrows on lower r&d expenses  TradingView Fri, 15 May 2026 11:07:40 GMT
 instil bio releases q1 2026 financial results  AlphaStreet Fri, 15 May 2026 07:00:00 GMT
 brief-instil bio q1 basic eps usd -0.62  TradingView Fri, 15 May 2026 07:00:00 GMT
 instil bio evaluates new drug deals, $74.7m cash lasts past 2027  Stock Titan Fri, 15 May 2026 07:00:00 GMT
 tradingkey  TradingKey Tue, 12 May 2026 20:59:56 GMT
 msn money  MSN Sun, 10 May 2026 04:14:23 GMT
 msn money  MSN Sat, 09 May 2026 05:22:26 GMT
 how instil bio inc. (til) affects rotational strategy timing  Stock Traders Daily Wed, 06 May 2026 09:30:02 GMT
 instil bio posts 41% eps beat, narrower loss, no revenue - final results  The Legal Advocate Sun, 03 May 2026 07:00:00 GMT
 instil bio shares rise on immunotherapy trial updates  MSN Mon, 27 Apr 2026 12:08:00 GMT
 instil bio shares rise on immunotherapy trial updates  MSN Sun, 26 Apr 2026 03:01:03 GMT
 (til) and the role of price-sensitive allocations  Stock Traders Daily Sat, 25 Apr 2026 07:00:00 GMT
 [ars] instil bio, inc. sec filing  Stock Titan Fri, 24 Apr 2026 07:00:00 GMT
 instil bio (nasdaq: til) sets 2026 vote and replaces deloitte  Stock Titan Fri, 24 Apr 2026 07:00:00 GMT
 instil bio, inc. investigated by the portnoy law firm  GlobeNewswire Mon, 20 Apr 2026 07:00:00 GMT
 til ownership | instil bio inc (nasdaq:til)  ChartMill Fri, 17 Apr 2026 07:00:00 GMT
 responsive playbooks and the til inflection  Stock Traders Daily Tue, 14 Apr 2026 07:14:01 GMT
 Instil Bio appoints RSM US as new auditor, replacing Deloitte & Touche  Investing.com Fri, 03 Apr 2026 07:00:00 GMT
 instil bio (til) replaces deloitte with rsm as independent auditor  Stock Titan Fri, 03 Apr 2026 07:00:00 GMT
 understanding the setup: (til) and scalable risk  Stock Traders Daily Fri, 03 Apr 2026 06:04:01 GMT
 til technical analysis & stock price forecast  Intellectia AI Wed, 01 Apr 2026 10:10:51 GMT
 til pe ratio & valuation, is til overvalued  intellectia.ai Wed, 01 Apr 2026 10:03:43 GMT
 ai investing insights - official homepage - intellectia ai™  Intellectia AI Tue, 31 Mar 2026 21:34:36 GMT
 til stock news today | earnings, events & price alerts  Intellectia AI Tue, 31 Mar 2026 21:34:36 GMT
 instil bio shares rise on immunotherapy trial updates  MSN Mon, 30 Mar 2026 14:09:06 GMT
 instil bio inc expected to post a loss of 59 cents a share - earnings preview  TradingView — Track All Markets Mon, 30 Mar 2026 07:00:00 GMT
 instil bio 2025 10-k: $(71.4)m net loss, $(10.70) loss per share  TradingView Fri, 27 Mar 2026 11:15:01 GMT
 instil bio (nasdaq: til) ends all r&d and warns on going concern  stocktitan.net Fri, 27 Mar 2026 11:05:40 GMT
 instil bio fy 2025 financial results & strategy update  grafa.com Fri, 27 Mar 2026 07:00:00 GMT
 instil bio q4 net loss per share narrows  TradingView Fri, 27 Mar 2026 07:00:00 GMT
 [8-k] instil bio, inc. reports material event  Stock Titan Fri, 27 Mar 2026 07:00:00 GMT
 after scrapping axn-2510, instil bio hunts for new drug deals  Stock Titan Fri, 27 Mar 2026 07:00:00 GMT
 brief-instil bio q4 basic eps usd -1.21  TradingView Fri, 27 Mar 2026 07:00:00 GMT
 the technical signals behind (til) that institutions follow  Stock Traders Daily Mon, 23 Mar 2026 07:00:00 GMT
 if you invested $1,000 in instil bio, inc. (til)  Stock Titan Sun, 22 Mar 2026 08:55:20 GMT
 precision trading with instil bio inc. (til) risk zones  Stock Traders Daily Thu, 12 Mar 2026 07:00:00 GMT
 til financials: income statement, balance sheet & cash flow  Stock Titan Tue, 03 Mar 2026 17:42:28 GMT
 til financials: income statement, balance sheet & cash flow  Stock Titan Sun, 01 Mar 2026 03:33:31 GMT
 technical reactions to til trends in macro strategies  Stock Traders Daily Sun, 01 Mar 2026 01:40:02 GMT
 til financials: income statement, balance sheet & cash flow  Stock Titan Wed, 25 Feb 2026 10:13:53 GMT
 trading the move, not the narrative: (til) edition  Stock Traders Daily Wed, 18 Feb 2026 08:00:00 GMT
 (til) volatility zones as tactical triggers  Stock Traders Daily Fri, 06 Feb 2026 08:00:00 GMT
 til should i buy  Intellectia AI Fri, 30 Jan 2026 08:00:00 GMT
 price-driven insight from (til) for rule-based strategy  Stock Traders Daily Mon, 26 Jan 2026 21:56:01 GMT

Instil Bio, Inc.
(NASDAQ:TIL) 

TIL stock logo

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, ...

Founded: 2018
CEO: Bronson Crouch  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends